They All Got Mysterious Brain Diseases. They're Fighting to Learn Why
A mysterious neurological syndrome in New Brunswick, Canada, has affected many young patients since 2018, causing cognitive decline and muscle spasms, with investigations facing political controversy and diminishing government support.
Read original articleclear explanation,” said Dr. Marrero. The investigation into the mysterious neurological syndrome in New Brunswick, Canada, has faced significant challenges since it began. Initially identified in 2018, the syndrome has affected numerous patients, many of whom are younger than typical for neurodegenerative diseases. Symptoms include severe cognitive decline, muscle spasms, and hallucinations, leading to confusion among medical professionals regarding diagnosis. Dr. Alier Marrero, a neurologist, reported over 20 cases to health authorities, prompting a national investigation. However, despite the urgency, no definitive cause has been established, and the situation has escalated into a political controversy, with accusations of government cover-ups and mismanagement. Environmental factors are suspected, as many patients reside in specific geographic areas, but proving a link to toxins remains complex. Initial government support for research was strong, but it has since waned, leading to frustration among patients and advocates. The ongoing mystery highlights the broader challenges in understanding neurodegenerative diseases, which often have unclear origins and overlapping symptoms, complicating diagnosis and treatment.
- A cluster of unexplained neurological diseases has emerged in New Brunswick, Canada, affecting many young patients.
- Symptoms include cognitive decline, muscle spasms, and hallucinations, leading to confusion in diagnosis.
- Investigations have faced political controversy and accusations of government cover-ups.
- Environmental factors are suspected, but proving a link to toxins is complex and challenging.
- Initial government support for research has diminished, causing frustration among affected families and advocates.
Related
Increase in people hospitalised with psychosis after prescribed cannabis
Doctors express concerns over increased psychosis hospitalizations linked to medicinal cannabis use. Calls for stricter regulations, especially for telehealth clinics and high-potency products. Emphasis on evidence-based treatments and limited THC products.
The Geopolitical Ramifications of Brain Fog
The article explores the geopolitical implications of brain fog, referencing President Biden's Covid-related brain fog. It draws parallels to historical pandemics, raises concerns about decision-making, and suggests invoking measures like the 25th Amendment.
A rare disorder makes people see monsters
Prosopometamorphopsia (PMO) distorts facial perceptions, affecting social interactions. Jason Werbeloff, diagnosed after mononucleosis, connects with researcher Brad Duchaine to study PMO's impact on facial recognition and emotional expression.
Cognitive decline and dementia in older adults diagnosed with Covid-19
A systematic review found a 65% incidence of new cognitive impairment in older adults with COVID-19. Time since infection may improve outcomes, highlighting the need for further research and diagnostic protocols.
Risk of cognitive decline and dementia in older adults with Covid-19: review
A systematic review found that 65% of older COVID-19 patients experienced new cognitive impairment, with a mean MoCA score of 23.34, highlighting the need for further research and management protocols.
https://www.globalresearch.ca/canadas-use-of-chemical-weapon...
During the war in Vietnam, the US tested agents orange, blue, and purple at CFB Gagetown. A 1968 U.S. Army memorandum titled “defoliation tests in 1966 at base Gagetown, New Brunswick, Canada” explained: “The department of the army, Fort Detrick, Maryland, has been charged with finding effective chemical agents that will cause rapid defoliation of woody and Herbaceous vegetation. To further develop these objectives, large areas similar in density to those of interest in South East Asia were needed. In March 1965, the Canadian ministry of defense offered Crops Division large areas of densely forested land for experimental tests of defoliant chemicals. This land, located at Canadian forces base Gagetown, Oromocto, New Brunswick, was suitable in size and density and was free from hazards and adjacent cropland. The test site selected contained a mixture of conifers and deciduous broad leaf species in a dense undisturbed forest cover that would provide similar vegetation densities to those of temperate and tropical areas such as South East Asia.”
New Brunswick oil and natural gas history:
https://www2.gnb.ca/content/dam/gnb/Corporate/pdf/ShaleGas/e...
It's a glaring omission either way that the NYTimes doesn't mention this at all...
Related
Increase in people hospitalised with psychosis after prescribed cannabis
Doctors express concerns over increased psychosis hospitalizations linked to medicinal cannabis use. Calls for stricter regulations, especially for telehealth clinics and high-potency products. Emphasis on evidence-based treatments and limited THC products.
The Geopolitical Ramifications of Brain Fog
The article explores the geopolitical implications of brain fog, referencing President Biden's Covid-related brain fog. It draws parallels to historical pandemics, raises concerns about decision-making, and suggests invoking measures like the 25th Amendment.
A rare disorder makes people see monsters
Prosopometamorphopsia (PMO) distorts facial perceptions, affecting social interactions. Jason Werbeloff, diagnosed after mononucleosis, connects with researcher Brad Duchaine to study PMO's impact on facial recognition and emotional expression.
Cognitive decline and dementia in older adults diagnosed with Covid-19
A systematic review found a 65% incidence of new cognitive impairment in older adults with COVID-19. Time since infection may improve outcomes, highlighting the need for further research and diagnostic protocols.
Risk of cognitive decline and dementia in older adults with Covid-19: review
A systematic review found that 65% of older COVID-19 patients experienced new cognitive impairment, with a mean MoCA score of 23.34, highlighting the need for further research and management protocols.